NCT04484818 2026-03-02Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE StudyEastern Cooperative Oncology GroupPhase 3 Active not recruiting27 enrolled